Gestational Diabetes: Pathophysiology, Risk, and Outcomes

Worldwide, gestational diabetes mellitus affects approximately 14% of pregnant women. Gestational diabetes can lead to increased risks for both the mother and the fetus, including preeclampsia, macrosomia, and/or fetal death. This webinar focuses on understanding the diagnostic criteria for gestational diabetes in addition to the management and appropriate postpartum follow-up to ensure optimal outcomes for both mother and baby.

After this webinar, participants will:

  • Understand the pathophysiology of gestational diabetes
  • Know the current ADA guidelines for the diagnosis of gestational diabetes
  • Understand the recommended lifetime follow-up care for women with a history of gestational diabetes


Jeanne Rhea-McManus, PhD, NRCC, DABCC, is currently a Medical Officer for Siemens Healthineers. She received her PhD in Genetics from the University of Georgia, and is board certified in Clinical Chemistry. Her past clinical research interests include HbA1c, diabetes, and the development and implementation of mass spectrometry methods in the clinical laboratory.